Eli Lilly (LLY) Advances While Market Declines: Some Information for Investors
https://www.zacks.com/stock/news/2246297/eli-lilly-lly-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2246297
Mar 26, 2024 - In the most recent trading session, Eli Lilly (LLY) closed at $774.90, indicating a +0.23% shift from the previous trading day.
0
Elie Hassenfeld Q&A: ‘$5,000 to Save a Life Is a Bargain’
https://www.wired.com/story/elie-hassenfeld-givewell-ea/
Mar 27, 2024 - As Sam Bankman-Fried’s downfall sends effective altruism into a spiral of self-doubt, the idealist quant Elie Hassenfeld is still helping Silicon Valley richies give away hundreds of millions each year.
0
Eli Lilly tops S&P 500 healthcare sector in Q1 as weight loss frenzy continues
https://seekingalpha.com/news/4084974-eli-lilly-tops-the-growth-chart-for-the-sp-500-index-in-q1-as-the-sector-gains-momentum?source=feed_sector_healthcare
Mar 30, 2024 - The Health Care Select Sector SPDR Fund ETF (XLV) lagged slightly behind the S&P 500 index in Q1 2024, rising 8.31% compared to the overall market's 10.04%...
0
Top Stock Reports for Apple, NVIDIA & Eli Lilly
https://www.zacks.com/commentary/2248263/top-stock-reports-for-apple-nvidia-eli-lilly?cid=CS-ZC-FT-research_daily-2248263
Apr 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), NVIDIA Corporation (NVDA) and Eli Lilly and Company (LLY).
0
Eli Lilly launches construction of $2.5B plant to meet obesity drug demand
https://seekingalpha.com/news/4088326-eli-lilly-eyes-25b-plant-make-obesity-drugs?source=feed_sector_healthcare
Apr 09, 2024 - Eli Lilly (LLY) begins construction of a $2.5B manufacturing plant in Germany to meet demand for its weight loss therapy tirzepatide. Read more here.
0
Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration
https://seekingalpha.com/news/4090270-eli-lilly-subsidiary-precision-biosciences-end-gene-therapy-collaboration?source=feed_sector_healthcare
Apr 16, 2024 - Precision BioSciences (DTIL) said Eli Lilly (LLY) subsidiary Prevail Therapeutics has decided to conclude their gene therapy collaboration. Read more here.
0
Top Research Reports for Eli Lilly, Linde & Caterpillar
https://www.zacks.com/commentary/2256781/top-research-reports-for-eli-lilly-linde-caterpillar?cid=CS-ZC-FT-research_daily-2256781
Apr 17, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and Caterpillar Inc. (CAT).
0
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential
https://www.fool.com/investing/2024/04/20/missed-out-eli-lilly-and-novo-nordisk-this-small/?source=iedfolrf0000001
Apr 20, 2024 - Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
0
Eli Lilly Just Announced More Good News: Time to Buy?
https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/?source=iedfolrf0000001
Apr 28, 2024 - There's no stopping this high-flying biotech.
0